Popular local drag performer will speak about diversity and inclusion at a special Pride event on Thursday June 29th
Rochester Clinical Research (RCR), announced that Mrs. Kasha Davis, a popular drag queen, actor and television personality is scheduled to speak at the “RCR Allyship Lunch & Learn” on Thursday June 29th, from 12pm-1pm. Davis is best known for competing on the seventh season of RuPaul’s Drag Race. A powerful voice in the LGBTQ+ community, she will be addressing the crucial significance of diversity and inclusion. The event is a staff event sponsored by the DEI Council at RCR. Contact DEIC@rcrclinical.com for any questions and details about the event.
Diversity is a fact. Inclusion is how we act.
“Diversity and inclusion are incredibly important in the clinical trial environment,” said Kelley Powers, VP of Strategy and Operations. At RCR, diversity and inclusion are not just a matter of fairness, she added, “it’s a matter of science.”
According to Powers, “A diverse environment leads to more diverse subjects. Diversity in clinical trials is vital for advancing scientific knowledge and improving healthcare outcomes, as it ensures fair representation of individuals from various backgrounds, fosters innovation, and enhances the applicability of research findings.”
At Rochester Clinical Research, we are committed to promoting Diversity, Equity, Inclusion and
Belonging (DEI) in all aspects of our clinical research activities. We strive to embrace diversity and treat all individuals with respect, understanding the importance of valuing their unique backgrounds and perspectives.
Moreover, by acknowledging and addressing systemic biases, we aim to ensure equitable opportunities for everyone, fostering an environment where everyone feels valued and empowered to contribute. We believe that by embracing diversity, we not only strengthen our research endeavors but also promote innovation and enhance the generalizability of our findings.
Our goal with this “RCR Allyship Lunch & Learn” is to build stronger relationships with the diverse LGBTQ+ community. We aim to foster a deeper understanding of scientific inquiry, so that clinical trials can achieve a richer racial composition and tap into the opportunity of advancing medical research.
About Rochester Clinical Research
Founded in 1994 by Patricia Larrabee, RCR is a multi-therapeutic clinical research “super site” operating out of a state-of-the-art 25,000 square foot facility in Rochester, NY. The Company has ten investigators, nearly 80 total employees and has completed more than 1,000 clinical studies since inception with exceptional patient enrollment and retention results.www.rcrclinical.com